Saturna Capital Corp Senseonics Holdings, Inc. Transaction History

Saturna Capital Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.02 - $2.23 $4,161 - $9,098	-4,080 Reduced 23.31%	13,420 $18,000
Q2 2022 Aug 12, 2022	SELL	$0.94 - $1.94 $60,160 - $124,160	-64,000 Reduced 78.53%	17,500 $18,000
Q1 2022 May 10, 2022	SELL	$1.54 - $3.71 $12,320 - $29,680	-8,000 Reduced 8.94%	81,500 $161,000
Q4 2021 Feb 09, 2022	BUY	$2.58 - $3.91 $3,870 - $5,865	1,500 Added 1.7%	89,500 $239,000
Q3 2021 Nov 08, 2021	BUY	$2.77 - $4.05 $8,310 - $12,150	3,000 Added 3.53%	88,000 $298,000
Q2 2021 Aug 11, 2021	BUY	$1.71 - $4.14 $145,350 - $351,900	85,000 New	85,000 $326,000

141

66.5M

505K

209K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $610M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Saturna Capital Corp with notifications on news.